World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
16381
World Ranking
2156
National Ranking
149

Overview

Carmen Scheibenbogen is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily falls within the field of Medicine, with significant contributions to subfields such as Psychiatry and Mental Health, Neurology, Rehabilitation, Cellular and Molecular Neuroscience, and Infectious Diseases.

The scientist's work extensively covers topics including Fibromyalgia and Chronic Fatigue Syndrome Research, Long-Term Effects of COVID-19, Exercise and Physiological Responses, Genetic Neurodegenerative Diseases, COVID-19 and Mental Health, Health, Psychology, and Well-being, as well as COVID-19 Clinical Research Studies.

Frequent coauthors collaborating with Scheibenbogen include Claudia Kedor, Franziska Sotzny, Uta Behrends, Kirsten Wittke, and Helma Freitag.

Publications by Scheibenbogen have appeared in several key venues, with the highest number of contributions in bioRxiv (Cold Spring Harbor Laboratory), followed by Frontiers in Immunology, Journal of Clinical Medicine, Journal of Translational Medicine, and Nature Communications.

Recent papers include the following:

  • A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity (2022, Nature Communications)
  • Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) (2022, Journal of Translational Medicine)
  • European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe (2021, Medicina)
  • Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study (2022, EClinicalMedicine)
  • S1-Leitlinie Post-COVID/Long-COVID (2021, Pneumologie)

Best Publications

  • Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis

    H. G. Leser;V. Gross;C. Scheibenbogen;A. Heinisch

  • Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses.

    Giulia Nizzoli;Jana Krietsch;Anja Weick;Svenja Steinfelder

  • Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

    Ulrich Keilholz;Jeffrey Weber;James H. Finke;Dmitry I. Gabrilovich

  • Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue

    Georg Wieczorek;Anne Asemissen;Fabian Model;Ivana Turbachova

  • A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

    Ulrich Keilholz;Anne Letsch;Antonia Busse;Anne Marie Asemissen

  • CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia.

    Carmen Scheibenbogen;Anne Letsch;Eckhard Thiel;Alexander Schmittel

  • Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

    Santa Rasa;Zaiga Nora-Krukle;Nina Henning;Eva Eliassen

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease

    Franziska Sotzny;Julià Blanco;Enrica Capelli;Jesús Castro-Marrero

  • Surface phenotype analysis of human monocyte to macrophage maturation.

    Reinhard Andreesen;Wolfram Brugger;Carmen Scheibenbogen;Marina Kreutz

  • Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.

    Madlen Loebel;Patricia Grabowski;Harald Heidecke;Sandra Bauer

  • Natural T cell immunity against cancer.

    Dirk Nagorsen;Carmen Scheibenbogen;Francesco M. Marincola;Anne Letsch

  • Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

    Ulrich Keilholz;Christian Conradt;Sewa S Legha;David Khayat

  • Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: A clinical report

    Marie Marchand;Marie Marchand;C. J.A. Punt;Steinar Aamdal;B. Escudier

  • Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

    U. Keilholz;Swan Hoo Goey;C. J. A. Punt;T. M. Proebstle

  • Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

    V Mailänder;C Scheibenbogen;E Thiel;A Letsch

  • Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity

    Unknown

  • Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory

    Anna Okhrimenko;Joachim R. Grün;Kerstin Westendorf;Zhuo Fang

  • Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay: a four-centre comparative trial

    Carmen Scheibenbogen;Pedro Romero;Licia Rivoltini;Wolfgang Herr

  • CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.

    O Penack;C Gentilini;L Fischer;A M Asemissen

  • Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

    Carmen Scheibenbogen;Alexander Schmittel;Ulrich Keilholz;Thomas Allgäuer

  • A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood.

    Peter Brossart;Johann-W. Schmier;Stefan Krüger;Martina Willhauck

  • Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells

    Licia Rivoltini;Chiara Castelli;Matteo Carrabba;Vincenzo Mazzaferro

  • Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ‐ELISPOT assay

    Carmen Scheibenbogen;Kang-Hun Lee;Stefan Stevanovic;Mathias Witzens

Frequent Co-Authors

Eckhard Thiel
Eckhard Thiel Charité - University Medicine Berlin
Ulrich Keilholz
Ulrich Keilholz Charité - University Medicine Berlin
Hans-Dieter Volk
Hans-Dieter Volk Charité - University Medicine Berlin
Heinz-Peter Schultheiss
Heinz-Peter Schultheiss Charité - University Medicine Berlin
Bernd Dörken
Bernd Dörken Charité - University Medicine Berlin
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin
Klemens Ruprecht
Klemens Ruprecht Charité - University Medicine Berlin
Petra Reinke
Petra Reinke Berlin-Brandenburger Centrum für Regenerative Therapien
Wolfram Doehner
Wolfram Doehner Charité - University Medicine Berlin
Christoph Loddenkemper
Christoph Loddenkemper Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open up diverse career pathways in healthcare. If you're interested in expanding your clinical skills, accelerated nurse practitioner programs offer a fast track to advanced practice roles, combining rigorous training with flexible online coursework.

Alternatively, many students without a nursing background consider enrolling in the best online BSN programs for non nurses, which provide a solid foundation in nursing tailored specifically for career changers.

For quicker entry into the nursing field, 12-month accelerated nursing programs can be an excellent option. These programs are designed for those seeking an intensive, time-efficient path to becoming a registered nurse.

Additionally, the fastest and easiest LPN programs provide entry-level nursing credentials in a shorter timeframe, ideal for individuals looking to start their healthcare careers swiftly.

Choosing any of these online programs can complement your immunology background and broaden your employment opportunities in healthcare and research sectors.

Best Scientists Citing Carmen Scheibenbogen

Trending Scientists

Recently Published Articles